A multicenter investigation of reablement in Norway: a clinical controlled trial

Abstract Background Reablement is an emerging approach in rehabilitation services, but evidence for its efficacy is rather weak and inconsistent. The purpose of the present study is therefore to investigate the health effects of reablement in home-dwelling adults. Methods A multicenter, clinical con...

Full description

Bibliographic Details
Main Authors: E. Langeland, H. Tuntland, B. Folkestad, O. Førland, F. F. Jacobsen, I. Kjeken
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Geriatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12877-019-1038-x
id doaj-a167277ee63e440db298d4da88ce5f95
record_format Article
spelling doaj-a167277ee63e440db298d4da88ce5f952020-11-25T01:21:41ZengBMCBMC Geriatrics1471-23182019-01-0119111210.1186/s12877-019-1038-xA multicenter investigation of reablement in Norway: a clinical controlled trialE. Langeland0H. Tuntland1B. Folkestad2O. Førland3F. F. Jacobsen4I. Kjeken5Centre for Care Research Western Norway, Western Norway University of Applied SciencesCentre for Care Research Western Norway, Western Norway University of Applied SciencesCentre for Care Research Western Norway, Western Norway University of Applied SciencesCentre for Care Research Western Norway, Western Norway University of Applied SciencesCentre for Care Research Western Norway, Western Norway University of Applied SciencesNational Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet HospitalAbstract Background Reablement is an emerging approach in rehabilitation services, but evidence for its efficacy is rather weak and inconsistent. The purpose of the present study is therefore to investigate the health effects of reablement in home-dwelling adults. Methods A multicenter, clinical controlled trial involving 47 municipalities in Norway, with assessments at baseline, and after 10 weeks and at 6 and 12 months. The sample consisted of 707 persons that received a 4–10 week reablement program and 121 underwent treatment as usual. Primary outcomes were activity performance and satisfaction with performance measured by the Canadian Occupational Performance Measure (COPM, 1–10). Secondary outcomes included the Short Physical Performance Measure Battery (SPPB), the European Quality of Life Scale (EQ-5D-5 L), and the Sense of Coherence Questionnaire (SOC). Overall treatment effects were estimated with mixed-model repeated measures analyses. Results Significant treatment effects in the rehabilitation group compared with the control group were found in COPM-Performance and COPM-Satisfaction scores at 10 weeks (mean differences between groups (MD), 1.61, 95% confidence interval (CI), 1.13, 2.10 and MD 1.47, CI 0.98, 1.97, respectively), and at 6 months (MD 1.42; CI 0.82,2.02 and MD 1.37; CI 0.77,1.98, respectively). There were also significant treatment effects in the SPPB-subscales for balance and walking after 6 months, in the total SPPB score and in the subscale for sit-to-stand after 12 months. In the EQ-5D-5 L assessment, significant treatment effects were found in the subscales for mobility, and for usual activities and health after 6 months. There was a significant difference in the SOC after six months. Conclusion Reablement seems to be a more effective rehabilitation service for persons with functional decline than traditional home-based services after six months. After 12 months, the differences between the groups decreased. Trial registration The trial was registered at ClinicalTrials.gov on October 24, 2014, (retrospectively registered) identifier: NCT02273934.http://link.springer.com/article/10.1186/s12877-019-1038-xActivities of daily livingAdultsClinical controlled trialHome-care servicesReablementRehabilitation
collection DOAJ
language English
format Article
sources DOAJ
author E. Langeland
H. Tuntland
B. Folkestad
O. Førland
F. F. Jacobsen
I. Kjeken
spellingShingle E. Langeland
H. Tuntland
B. Folkestad
O. Førland
F. F. Jacobsen
I. Kjeken
A multicenter investigation of reablement in Norway: a clinical controlled trial
BMC Geriatrics
Activities of daily living
Adults
Clinical controlled trial
Home-care services
Reablement
Rehabilitation
author_facet E. Langeland
H. Tuntland
B. Folkestad
O. Førland
F. F. Jacobsen
I. Kjeken
author_sort E. Langeland
title A multicenter investigation of reablement in Norway: a clinical controlled trial
title_short A multicenter investigation of reablement in Norway: a clinical controlled trial
title_full A multicenter investigation of reablement in Norway: a clinical controlled trial
title_fullStr A multicenter investigation of reablement in Norway: a clinical controlled trial
title_full_unstemmed A multicenter investigation of reablement in Norway: a clinical controlled trial
title_sort multicenter investigation of reablement in norway: a clinical controlled trial
publisher BMC
series BMC Geriatrics
issn 1471-2318
publishDate 2019-01-01
description Abstract Background Reablement is an emerging approach in rehabilitation services, but evidence for its efficacy is rather weak and inconsistent. The purpose of the present study is therefore to investigate the health effects of reablement in home-dwelling adults. Methods A multicenter, clinical controlled trial involving 47 municipalities in Norway, with assessments at baseline, and after 10 weeks and at 6 and 12 months. The sample consisted of 707 persons that received a 4–10 week reablement program and 121 underwent treatment as usual. Primary outcomes were activity performance and satisfaction with performance measured by the Canadian Occupational Performance Measure (COPM, 1–10). Secondary outcomes included the Short Physical Performance Measure Battery (SPPB), the European Quality of Life Scale (EQ-5D-5 L), and the Sense of Coherence Questionnaire (SOC). Overall treatment effects were estimated with mixed-model repeated measures analyses. Results Significant treatment effects in the rehabilitation group compared with the control group were found in COPM-Performance and COPM-Satisfaction scores at 10 weeks (mean differences between groups (MD), 1.61, 95% confidence interval (CI), 1.13, 2.10 and MD 1.47, CI 0.98, 1.97, respectively), and at 6 months (MD 1.42; CI 0.82,2.02 and MD 1.37; CI 0.77,1.98, respectively). There were also significant treatment effects in the SPPB-subscales for balance and walking after 6 months, in the total SPPB score and in the subscale for sit-to-stand after 12 months. In the EQ-5D-5 L assessment, significant treatment effects were found in the subscales for mobility, and for usual activities and health after 6 months. There was a significant difference in the SOC after six months. Conclusion Reablement seems to be a more effective rehabilitation service for persons with functional decline than traditional home-based services after six months. After 12 months, the differences between the groups decreased. Trial registration The trial was registered at ClinicalTrials.gov on October 24, 2014, (retrospectively registered) identifier: NCT02273934.
topic Activities of daily living
Adults
Clinical controlled trial
Home-care services
Reablement
Rehabilitation
url http://link.springer.com/article/10.1186/s12877-019-1038-x
work_keys_str_mv AT elangeland amulticenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT htuntland amulticenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT bfolkestad amulticenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT oførland amulticenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT ffjacobsen amulticenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT ikjeken amulticenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT elangeland multicenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT htuntland multicenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT bfolkestad multicenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT oførland multicenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT ffjacobsen multicenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
AT ikjeken multicenterinvestigationofreablementinnorwayaclinicalcontrolledtrial
_version_ 1725129068097044480